Wanhua Chemical Group Co.,Ltd. has unveiled a first-half scorecard that has captured the market's attention. For the first six months of 2026, the company recorded operating revenue of RMB 119.316 billion, a substantial year-on-year increase of 31.26%. Net profit attributable to shareholders of the listed company reached RMB 10.063 billion, leaping 64.35% higher, with profit growth significantly outpacing revenue expansion, underscoring a marked improvement in profitability.
The earnings elasticity is particularly striking. During the reporting period, total profit hit RMB 13.968 billion, an 85.53% surge year-on-year, while net profit excluding non-recurring items reached RMB 9.676 billion, up 54.96%. This signals that the growth is rooted in genuine improvements to the core business rather than one-off gains. Basic earnings per share rose from RMB 1.95 in the prior-year period to RMB 3.21, a 64.62% increase, delivering enhanced shareholder returns.
Asset scale and shareholder equity have expanded in tandem, with financial health continuing to solidify. As of the end of June 2026, total assets stood at RMB 354.152 billion, up 9.64% from the start of the year, while net assets attributable to shareholders reached RMB 113.596 billion, a 4.89% increase. The weighted average return on equity (ROE) climbed from 6.24% to 8.96% year-on-year, a jump of 2.72 percentage points, reflecting notably improved asset efficiency.
On the cash flow front, net cash generated from operating activities amounted to RMB 11.784 billion, up 11.93% year-on-year, demonstrating robust cash-generating capacity from the core operations. The company also unveiled an interim dividend plan, proposing a cash distribution of RMB 8.10 per 10 shares (pre-tax), totaling approximately RMB 2.536 billion, as a tangible reward to investors.
Revenue Achieves Leapfrog Growth, Single Quarter Sets New Record
In the first half of 2026, Wanhua Chemical generated operating revenue of RMB 119.316 billion, adding roughly RMB 28.4 billion compared with RMB 90.901 billion in the same period last year, a growth rate of 31.26%.
This pace places the company among the top tier of chemical industry leaders, reflecting a pattern of simultaneous volume and price gains across its core segments of MDI, petrochemicals, and advanced materials.
The revenue growth rate significantly outpaces the industry average, driven on one hand by the company's ongoing capacity expansion strategy—new and expanded units at bases in Yantai, Ningbo, and Fujian are gradually contributing output. On the other hand, a cyclical recovery in global chemical demand has provided a favorable external environment for sales growth. Notably, revenue climbed 31% while net profit surged 64%, displaying a classic pattern of profit elasticity outpacing revenue elasticity, which indicates that economies of scale and cost management have jointly driven a substantial lift in per-unit profitability.
Profitability Rises Across the Board, ROE Returns to High Levels
Earnings quality stands out as one of the most noteworthy highlights of this report. Total profit grew 85.53%, net profit increased 64.35%, and net profit excluding non-recurring items rose 54.96%—all three metrics substantially outpaced revenue growth, indicating effective cost control, optimized raw material expenses, and an upgraded product mix.
The weighted average ROE rebounded from 6.24% to 8.96%, a single-period improvement of 2.72 percentage points, edging closer to the key 10% threshold. For a capital-intensive chemical enterprise with assets exceeding RMB 350 billion, this is no small feat. Should second-half profitability hold at comparable levels, the full-year ROE could climb further, supporting a re-rating of the company's valuation framework.
Stable Operating Cash Flow Supports Heavy Capital Expenditure
Net cash from operating activities reached RMB 11.784 billion, up approximately 11.93% year-on-year. While the growth rate lags net profit expansion, the absolute scale remains substantial, indicating the company retains strong internal capital generation during its high-growth phase.
This robust cash flow underpins Wanhua Chemical's continued capital spending. The company remains in a large-scale investment expansion cycle, with multiple billion-level projects under construction, including ethylene cracking, advanced materials, and fine chemical value-chain extensions. Strong cash inflows have effectively reduced reliance on external financing, preserving a healthy balance sheet.
Clear Debt Structure, Dense Issuance of Sci-Tech Innovation Bonds
In terms of outstanding bonds, Wanhua Chemical held multiple tranches of medium-term notes and short-term financing bills during the reporting period, totaling over RMB 11.2 billion, with coupon rates concentrated in the 1.56% to 2.30% range, keeping overall financing costs at historic lows.
Worth noting is the company's recent dense issuance of science-and-technology innovation bonds and green sci-tech innovation bonds, spanning multiple batches from 2025 to 2026, with proceeds directed toward R&D and green industrial upgrades. This shift in financing structure aligns with national policy directions and reflects the company's strategic transition from scale expansion to technology-driven growth.
Stable Shareholding Structure, Clear State-Owned Dominance
As of the end of the reporting period, the company had 238,852 shareholders in total. The top three shareholders—Yantai Guofeng Investment Holding Group (21.65%), Yantai Zhongcheng Investment (10.55%), and Ningbo Zhongkaixin Venture Capital (9.64%)—are parties acting in concert, holding a combined stake exceeding 41%, ensuring a stable state-owned-led control structure and continuity in strategic decision-making.
Hong Kong Securities Clearing Company Ltd. holds 5.74%, while the Abu Dhabi Investment Authority holds 0.80%, indicating that Wanhua Chemical maintains notable appeal among international institutional investors. The National Social Security Fund's 103 and 114 portfolios together hold more than 1.74%, with long-term capital remaining committed, underscoring market recognition of its long-term investment value.
Generous Dividend: RMB 8.10 Per 10 Shares
The board has approved an interim profit distribution plan: based on the total share capital of 3.13 billion shares at the end of the reporting period, the company will distribute a cash dividend of RMB 8.10 per 10 shares (pre-tax) to all shareholders, totaling approximately RMB 2.536 billion, with the remaining undistributed profit of RMB 62.803 billion carried forward to future years.
In terms of payout ratio, the RMB 2.536 billion interim dividend represents roughly 25.2% of the current period's net profit of RMB 10.063 billion, reflecting the company's commitment to shareholder returns. Meanwhile, the substantial retained earnings of RMB 62.8 billion provide ample financial buffer for future capital expenditures and industrial deployment, striking a balance between near-term returns and long-term development.
Comments